-
Mashup Score: 1
Investigators plan to reinitiate enrollment of patients with non-Hodgkin lymphoma as part of the phase 1a/1b NX-2127-001 trial.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 29Volume 143 Issue 10 | Blood | American Society of Hematology - 22 day(s) ago
Read the current issue of Blood.
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 29Volume 143 Issue 10 | Blood | American Society of Hematology - 22 day(s) ago
Read the current issue of Blood.
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5Diagnosing and Treating Blastic Plasmacytoid Dendritic Cell Neoplasm in a Resource-Limited Setting - 22 day(s) ago
A recent clinical quandary focused on the diagnosis and treatment of blastic plasmacytoid dendritic cell neoplasm in a resource-limited setting.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 18Volume 143 Issue 9 | Blood | American Society of Hematology - 29 day(s) ago
Read the current issue of Blood.
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Recent Approvals Across Hematologic Malignancies Usher in a New Era - 1 month(s) ago
Mikkael A. Sekeres, MD, MS, highlights recent approvals and emerging therapeutics in hematologic malignancies discussed by his colleagues.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 29Volume 143 Issue 8 | Blood | American Society of Hematology - 1 month(s) ago
Read the current issue of Blood.
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0FDA Accepts NDA Resubmission for Dasynoc in CML - 1 month(s) ago
A new drug application for Dasynoc, a protein kinase inhibitor product candidate for patients with chronic myeloid leukemia, has been accepted by the FDA.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5Diagnosing Blastic Plasmacytoid Dendritic Cell Neoplasm - 1 month(s) ago
Sangeetha Venugopal, MD, MS, provides an overview of how patients with blastic plasmacytoid dendritic cell neoplasms (BPDCN) are diagnosed.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 20ASH Journal Club - 1 month(s) ago
The ASH Journal Club is a series that highlights seminal papers in hematology published in Blood and Blood Advances and features a manuscript author as part of the engagement. Click ‘Enroll Now’ to view recordings of previous webinars and see upcoming events in
Source: academy.hematology.orgCategories: General Medicine News, Onc News and JournalsTweet
The FDA has lifted its partial clinical hold on the phase 1a/1b NX-2127-001 trial assessing treatment with NX-2127 for adult patients with relapsed/refractory B-cell malignancies. #hematology | @US_FDA @FDAOncology https://t.co/I8ScfbEHaz